Single fraction urethra-sparing prostate cancer SBRT: Phase I results of the ONE SHOT trial.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 31431369.
- Also identified by DOI 10.1016/j.radonc.2019.07.018.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The ONE SHOT trial is the first phase I/II prospective, multicenter, single-arm study assessing the efficacy and safety of a single-dose SBRT for men with localized prostate cancer. Aim of this paper is to present the phase I results of a 19 Gy single fraction urethra-sparing SBRT with real-time electromagnetic tracking.
Medical subject headings
- Prostatic Neoplasms
- Radiosurgery
- Radiotherapy, Image-Guided
- Urethra